DSAM Partners’s Health Catalyst HCAT Stock Holding History

DSAM Partners’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,729	Closed	-$245K	–	64
2019 Q3	$245K	Buy	+7,729	New	+$304K	0.05%	63

Other funds holding HCAT

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

NVPX

Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return

NVPX

Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DSAM Partners's HCAT Position: Q4 2019 in Review

DSAM Partners sold out of Health Catalyst (HCAT) in Q4 2019, closing a stake of 7,729 shares — an estimated $245K sold.

DSAM Partners first reported a position in HCAT in Q3 2019 and held it in 1 quarter. The position peaked at $245K in Q3 2019. 88 funds tracked by Wall St. Rank hold HCAT as of Q4 2019.

DSAM Partners reported no remaining Health Catalyst position as of Q4 2019 after selling out during the quarter.
DSAM Partners sold 7,729 Health Catalyst shares in Q4 2019, an estimated $245K.
DSAM Partners first reported a position in Health Catalyst in Q3 2019 and held it in 1 quarter.
DSAM Partners's Health Catalyst position peaked at $245K in Q3 2019.
88 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2019.

Based on DSAM Partners's 13F filing for Q4 2019, filed 14 Feb 2020.